These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30826344)

  • 1. Indole-3 acetic acid increased risk of impaired cognitive function in patients receiving hemodialysis.
    Lin YT; Wu PH; Lee HH; Mubanga M; Chen CS; Kuo MC; Chiu YW; Kuo PL; Hwang SJ
    Neurotoxicology; 2019 Jul; 73():85-91. PubMed ID: 30826344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis.
    Deltombe O; Van Biesen W; Glorieux G; Massy Z; Dhondt A; Eloot S
    Toxins (Basel); 2015 Sep; 7(10):3933-46. PubMed ID: 26426048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring binding characteristics and the related competition of different protein-bound uremic toxins.
    Deltombe O; de Loor H; Glorieux G; Dhondt A; Van Biesen W; Meijers B; Eloot S
    Biochimie; 2017 Aug; 139():20-26. PubMed ID: 28528271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adsorption of Protein-Bound Uremic Toxins Through Direct Hemoperfusion With Hexadecyl-Immobilized Cellulose Beads in Patients Undergoing Hemodialysis.
    Yamamoto S; Sato M; Sato Y; Wakamatsu T; Takahashi Y; Iguchi A; Omori K; Suzuki Y; Ei I; Kaneko Y; Goto S; Kazama JJ; Gejyo F; Narita I
    Artif Organs; 2018 Jan; 42(1):88-93. PubMed ID: 28703401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-bound uremic toxins are associated with cognitive function among patients undergoing maintenance hemodialysis.
    Lin YT; Wu PH; Liang SS; Mubanga M; Yang YH; Hsu YL; Kuo MC; Hwang SJ; Kuo PL
    Sci Rep; 2019 Dec; 9(1):20388. PubMed ID: 31892730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein-Bound Uremic Toxins in Hemodialysis Patients Relate to Residual Kidney Function, Are Not Influenced by Convective Transport, and Do Not Relate to Outcome.
    van Gelder MK; Middel IR; Vernooij RWM; Bots ML; Verhaar MC; Masereeuw R; Grooteman MP; Nubé MJ; van den Dorpel MA; Blankestijn PJ; Rookmaaker MB; Gerritsen KGF
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32272776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective Transport of Protein-Bound Uremic Toxins in Erythrocytes.
    Deltombe O; Glorieux G; Marzouki S; Masereeuw R; Schneditz D; Eloot S
    Toxins (Basel); 2019 Jul; 11(7):. PubMed ID: 31266243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the adequacy parameter Kt/V(urea) reflect uremic toxin concentrations in hemodialysis patients?
    Eloot S; Van Biesen W; Glorieux G; Neirynck N; Dhondt A; Vanholder R
    PLoS One; 2013; 8(11):e76838. PubMed ID: 24236005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indole 3-acetic acid, indoxyl sulfate and paracresyl-sulfate do not influence anemia parameters in hemodialysis patients.
    Bataille S; Pelletier M; Sallée M; Berland Y; McKay N; Duval A; Gentile S; Mouelhi Y; Brunet P; Burtey S
    BMC Nephrol; 2017 Jul; 18(1):251. PubMed ID: 28747155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Uremic Score Reflecting Accumulation of Specific Uremic Toxins More Precisely Predicts One-Year Mortality after Hemodialysis Commencement: A Retrospective Cohort Study.
    Arai Y; Shioji S; Tanaka H; Katagiri D; Hinoshita F
    Toxins (Basel); 2020 Oct; 12(10):. PubMed ID: 33019590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the montreal cognitive assessment and the mini-mental state examination as screening tests in hemodialysis patients without symptoms.
    Lee SH; Cho A; Min YK; Lee YK; Jung S
    Ren Fail; 2018 Nov; 40(1):323-330. PubMed ID: 29633885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Low Ankle-Brachial Index and High Brachial-Ankle Pulse Wave Velocity Are Associated with Poor Cognitive Function in Patients Undergoing Hemodialysis.
    Wu PH; Lin YT; Wu PY; Huang JC; Chen SC; Chang JM; Chen HC
    Dis Markers; 2019; 2019():9421352. PubMed ID: 31531128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of Bone Turnover Markers with Cognitive Function in Patients Undergoing Hemodialysis.
    Wu PH; Lin YT; Chen CS; Chiu YW; Tsai JC; Kuo PL; Hsu YL; Ljunggren Ö; Fellström B; Kuo MC
    Dis Markers; 2020; 2020():8641749. PubMed ID: 32377274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum substances that interfere with thyroid hormone assays in patients with chronic renal failure.
    Iitaka M; Kawasaki S; Sakurai S; Hara Y; Kuriyama R; Yamanaka K; Kitahama S; Miura S; Kawakami Y; Katayama S
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):739-46. PubMed ID: 9713563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of organic anion transporters in the efflux of uremic toxins across the blood-brain barrier.
    Deguchi T; Isozaki K; Yousuke K; Terasaki T; Otagiri M
    J Neurochem; 2006 Feb; 96(4):1051-9. PubMed ID: 16445853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Montreal Cognitive Assessment (MoCA) - a sensitive screening instrument for detecting cognitive impairment in chronic hemodialysis patients.
    Tiffin-Richards FE; Costa AS; Holschbach B; Frank RD; Vassiliadou A; Krüger T; Kuckuck K; Gross T; Eitner F; Floege J; Schulz JB; Reetz K
    PLoS One; 2014; 9(10):e106700. PubMed ID: 25347578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Levels and Removal by Haemodialysis and Haemodiafiltration of Tryptophan-Derived Uremic Toxins in ESKD Patients.
    Paats J; Adoberg A; Arund J; Dhondt A; Fernström A; Fridolin I; Glorieux G; Leis L; Luman M; Gonzalez-Parra E; Perez-Gomez VM; Pilt K; Sanchez-Ospina D; Segelmark M; Uhlin F; Arduan Ortiz A
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uremic Toxic Blood-Brain Barrier Disruption Mediated by AhR Activation Leads to Cognitive Impairment during Experimental Renal Dysfunction.
    Bobot M; Thomas L; Moyon A; Fernandez S; McKay N; Balasse L; Garrigue P; Brige P; Chopinet S; Poitevin S; Cérini C; Brunet P; Dignat-George F; Burtey S; Guillet B; Hache G
    J Am Soc Nephrol; 2020 Jul; 31(7):1509-1521. PubMed ID: 32527975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors of microinflammation in non-diabetic chronic kidney disease: a pilot study.
    Olivier V; Dunyach-Remy C; Corbeau P; Cristol JP; Sutra T; Burtey S; Lavigne JP; Moranne O
    BMC Nephrol; 2020 Apr; 21(1):141. PubMed ID: 32316931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uremic toxins overload accelerates renal damage in a rat model of chronic renal failure.
    Satoh M; Hayashi H; Watanabe M; Ueda K; Yamato H; Yoshioka T; Motojima M
    Nephron Exp Nephrol; 2003; 95(3):e111-8. PubMed ID: 14646363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.